What is NDC 51662-1574?

51662-1574 is the product NDC for Furosemide, Furosemide 10 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Furosemide?

211 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Furosemide NDC 51662-1574 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1574Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1574Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1574-1	51662157401	4 mL in 1 VIAL (51662-1574-1)Marketed from Jun 28, 2021
51662-1574-3	51662157403	25 POUCH in 1 CASE (51662-1574-3) / 1 VIAL in 1 POUCH (51662-1574-2) / 4 mL in 1 VIALMarketed from Jun 28, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Furosemide
Generic name (nonproprietary): furosemide
Active ingredients: Furosemide — 10 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018902
Marketing start: Jun 28, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 51662-1574_100cb889-1a7e-6252-e063-6394a90a9221SPL ID 100cb889-1a7e-6252-e063-6394a90a9221SPL set ID c5db4434-0b47-038c-e053-2995a90ad7feRxCUI 1719291UNII 7LXU5N7ZO5UPC 0363323280031
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662157401 followed by a unit qualifier and the quantity

Package 51662-1574-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE Parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. Edema Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired. Furosemide is indicated as adjunctive therapy in acute pulmonary edema. The IV administration of furosemide is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema. If gastrointestinal absorption is impaired or oral m…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1574

What is NDC 51662-1574?: 51662-1574 is the product NDC for Furosemide, Furosemide 10 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Furosemide.
What is the active ingredient?: Furosemide.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Furosemide?: 211 other product NDCs are listed under this name. See all Furosemide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Furosemide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Furosemide	Furosemide 10 mg/mL	InjectionIntramuscular, Intravenous	Civica, Inc.	72572-275	72572-0275-10
Furosemide	Furosemide 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-4679	70518-4679-00
Furosemide	Furosemide 20 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-033	87441-0033-01
Furosemide	Furosemide 20 mg/1	TabletOral	Coupler LLC	67046-0768	67046-0768-03
Furosemide	Furosemide 40 mg/1	TabletOral	REMEDYREPACK INC.	70518-4609	70518-4609-00
Furosemide	Furosemide 40 mg/1	TabletOral	Coupler LLC	67046-1663	67046-1663-03
Furosemide	Furosemide 40 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-833	10135-0833-0110135-0833-1010135-0833-90
Furosemide	Furosemide 80 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-834	10135-0834-0110135-0834-0510135-0834-90
Furosemide	Furosemide 20 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-832	10135-0832-0110135-0832-1010135-0832-90
Furosemide	Furosemide 40 mg/1	TabletOral	Granulation Technology, Inc.	63561-0165	63561-0165-0163561-0165-0263561-0165-09

All 212 Furosemide NDCs

Other NDCs under NDA 018902

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018902
Product	Strength	Form · route	Labeler	Product NDC
Furosemide	Furosemide 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	63323-280
Furosemide	Furosemide 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	63323-280
Furosemide	Furosemide 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Phlow Corporation	81565-201
Furosemide	Furosemide 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Cardinal Health 107, LLC	55154-9581
Furosemide	Furosemide 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Cardinal Health 107, LLC	55154-9582
Furosemide	Furosemide 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1572
Furosemide	Furosemide 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1575